Stratasys Creates 3...
Health Care: Drugs
Puma Biotechnology Inc (PBYI: NYSE)
$36.70 -0.15 | -0.41%
05/22/13 - 04:02 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| PBYI | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 52.65 | 189.02 | 0.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | |
| Net Income | 4415.25 | 0.00 | |
| EPS | 341.00 | 0.00 |
Earnings for PBYI:
| EBITDA | -74.00 |
| REVENUE | 0.00 |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.62 | $-0.64 | $-2.44 | $-1.89 |
| Number of Analysts | 5 | 5 | 5 | 4 |
| High Estimate | $-0.39 | $-0.39 | $-1.58 | $-0.68 |
| Low Estimate | $-0.94 | $-0.97 | $-3.82 | $-2.93 |
| Prior Year | $-0.74 | $-1.29 | $-1.68 | $-2.44 |
| Growth Rate (Year over Year) | 16.49% | 50.54% | -45.36% | 22.60% |
Portfolios with PBYI
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
Latest PBYI Headlines from TheStreet
- 3 Stocks Spiking on Big Volume 04.15.13 | 02:04 pm
- Top Insider Trades: NSH PBYI CONN EPHC 12.12.12 | 09:12 am
- Insiders Trading BLK FIRE SONS PBYI 10.23.12 | 09:10 am
- Insiders Trading NCT, PBYI, NAV, OPK 07.30.12 | 01:07 pm
- Insiders Trading FDO, PBYI, SUMR, ENTG 07.19.12 | 09:07 am
- Top Insider Trades: SPB PBYI GPK AXS 12.31.69 | 07:12 pm
Press Releases for PBYI
- Puma Biotechnology To Present At Cowen Healthcare Conference - Business Wire 02.26.13 | 08:02 am
- Puma Biotechnology Announces Agreement With FDA On Special Protocol Assessment For Phase III Trial Of PB272 (Neratinib) In HER2-Positive Metastatic Breast Cancer Patients - Business Wire 02.20.13 | 08:02 am
- Puma Biotechnology To Present At Leerink Swann Global Healthcare Conference - Business Wire 02.06.13 | 08:02 am
- Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data At CTRC-AACR San Antonio Breast Cancer Symposium - Business Wire 12.07.12 | 06:12 pm
- Puma Biotechnology Reports Third Quarter 2012 Financial Results - Business Wire 11.14.12 | 08:11 am
- Puma Biotechnology To Present At Lazard Healthcare Conference - Business Wire 11.07.12 | 08:11 am
- Puma Biotechnology Closes $138 Million Public Offering Of Common Stock - Business Wire 10.24.12 | 02:10 pm
- Puma Biotechnology Announces Underwriters’ Full Exercise Of Overallotment Option, Increasing Total Offering Size To $138 Million - Business Wire 10.22.12 | 08:10 am
- Puma Biotechnology Announces Upsizing And Pricing Of $120 Million Public Offering Of Common Stock - Business Wire 10.18.12 | 06:10 pm
- Puma Biotechnology To Present At UBS Global Life Sciences Conference - Business Wire 09.12.12 | 08:09 am
Partner Headlines for PBYI
- Analysts: CarMax Can Maintain Momentum and 3 New Opinions Investors Must Take a Peek At - Wall St. Cheat Sheet 04.02.13 | 11:04 am
- Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR) - Benzinga 03.23.13 | 11:03 am
